Skip to content

Nektar Therapeutics

NKTR· NasdaqCore metricsCIK 906709

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -2.76%
Market cap
$1.28B
34.21M shares
Filings
1,046
$9.39M
Q3 2026−43.9% FY25 yoy
-$55.65M
Q3 2026N/M FY25 yoy
-$57.80M
Q3 2026N/M FY25 yoy
-$192.51M
Q3 2026derivedN/M FY25 yoy
-$1.63
Q3 2026N/M FY25 yoy
$34.69M
Q3 2026−65.8% FY25 yoy
$1.28B
—
24.4×
1.5×
-20.18%
—

Twelve months to Sep 30, 2026 · derived

Price

$37.2937.07%$21.97past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$55.23MFY 2025
$1.19B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$55,232,000reported
FY 20242024-12-31$98,427,000reported
FY 20232023-12-31$90,122,000reported
FY 20222022-12-31$92,055,000reported
FY 20212021-12-31$101,907,000reported
FY 20202020-12-31$152,915,000reported
FY 20192019-12-31$114,617,000reported
FY 20182018-12-31$1,193,323,000reported
FY 20172017-12-31$307,711,000reported
FY 20162016-12-31$165,436,000reported
FY 20152015-12-31$230,784,000reported
FY 20142014-12-31$200,707,000reported

Capital returns

Dividends and buybacks · FY2023 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$0.00$0.00—28.69M sh−84.6%—
FY2024—$3.00M$3.00M—186.10M sh+1.4%—
FY2023—$0.00$0.00—183.62M sh−3.0%—

Segments

Long-lived assets by Geography, FY2019 to FY2021FY2019United States · FY2019 · $59.70MIndia · FY2019 · $5.30MFY2020United States · FY2020 · $54.50MIndia · FY2020 · $5.10MFY2021United States · FY2021 · $56.10MIndia · FY2021 · $4.40M
LineFY2021ShareChange
United States$56.10M93%+2.9%
India$4.40M7.3%−13.7%
Total$60.51M

From the 10-K filed Feb 28, 2023NKTR

Pharmaceutical preparations

Nektar Therapeutics is the 124th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Nektar Therapeutics · CIK 906709 · Engraved from SEC EDGAR